Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cytokine

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/CYTO.2000.0850PMID 11298493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferons and interferon (IFN)‐inducible protein 10 during highly active anti‐retroviral therapy (HAART)—possible immunosuppressive role of IFN‐α in HIV infection

  2000cited by this paper
• Candida albicans and Candida krusei Differentially Induce Human Blood Mononuclear Cell Interleukin-12 and Gamma Interferon Production

  2000cited by this paper
• Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency.

  1999cited by this paper
• Interferons and their role In inflammation.

  1999cited by this paper
• IL‐10 in HIV infection: increasing serum IL‐10 levels with disease progression—down‐regulatory effect of potent anti‐retroviral therapy

  1999cited by this paper
• The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals.

  1999cited by this paper
• Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study).

  1999cited by this paper
• The taming of IL‐12: suppressing the production of proinflammatory cytokines

  1999cited by this paper
• Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

  1999cited by this paper
• IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression.

  1998cited by this paper
• Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite.

  1998cited by this paper
• Randomized, controlled phase II trial of subcutaneous interleukin‐2 in combination with highly active antiretroviral therapy (HAART) in HIV patients

  1998cited by this paper
• Low dose Oral Interferon Alpha 2a in HIV-1 Seropositive Patients: A Double-blind, Placebo-controlled Trial

  1998cited by this paper
• Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

  1998cited by this paper
• How cells respond to interferons.

  1998cited by this paper
• Type 1 Interferon (IFNα/β) and Type 2 Nitric Oxide Synthase Regulate the Innate Immune Response to a Protozoan Parasite

  1998cited by this paper
• Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection.

  1997cited by this paper
• Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection

  1997cited by this paper
• Host factors and the pathogenesis of HIV-induced disease

  1996cited by this paper
• Lymphoblastoid Interferon-α Inhibits T Cell Proliferation and Expression of Eosinophil-Activating Cytokines

  1996cited by this paper
• Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes.

  1996cited by this paper
• In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10.

  1996cited by this paper
• Interleukin-12 in the pathogenesis and therapy of HIV disease.

  1995cited by this paper
• Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens

  1995cited by this paper
• Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

  1994cited by this paper
• Properties and functions of interleukin-10.

  1994cited by this paper
• Interferons in the pathogenesis and treatment of human immunodeficiency virus infection.

  1994cited by this paper
• Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells.

  1994cited by this paper
• Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

  1994cited by this paper
• Immune-based therapeutics: scientific rationale and the promising approaches to the treatment of the human immunodeficiency virus-infected individual.

  1993cited by this paper
• A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

  1993cited by this paper
• Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.

  1993cited by this paper
• Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

  1993cited by this paper
• Interferons in the Persistence, Pathogenesis, and Treatment of HIV Infection

  1992cited by this paper
• Natural Human Interferon-α Augments Interleukin-2 Production by a Direct Action on the Activated IL-2–Producing T Cells

  1991cited by this paper
• The interferons. Mechanisms of action and clinical applications.

  1991cited by this paper
• Impaired in vitro survival of monocytes from patients with HIV infection

  1990cited by this paper
• Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

  1989cited by this paper
• Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

  1988cited by this paper
• Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

  1983cited by this paper

• Distinct Type I Interferon Subtypes Differentially Stimulate T Cell Responses in HIV-1-Infected Individuals

  2022cites this paper
• Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection

  2022cites this paper
• Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure

  2018cites this paper
• The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy

  2017cites this paper
• Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis

  2014cites this paper
• Increased Systemic and Local Interleukin 9 Levels in Patients with Carotid and Coronary Atherosclerosis

  2013cites this paper
• Peri- and extravascular inflammation : impact on atherosclerosis

  2012cites this paper
• Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation.

  2009cites this paper
• Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency.

  2009cites this paper
• An unusual clinical presentation: invasive Candida non-albicans infections in ataxia telangiectasia.

  2008cites this paper
• A Potential Role of the CXC Chemokine GROα in Atherosclerosis and Plaque Destabilization: Downregulatory Effects of Statins

  2008cites this paper
• Human thymic dendritic cells: regulators of T cell development in health and HIV-1 infection.

  2008cites this paper
• Inflammatory Interaction Between LIGHT and Proteinase-Activated Receptor-2 in Endothelial Cells: Potential Role in Atherogenesis

  2008cites this paper
• Enhanced Expression of the Homeostatic Chemokines CCL19 and CCL21 in Clinical and Experimental Atherosclerosis: Possible Pathogenic Role in Plaque Destabilization

  2007cites this paper
• Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo

  2007cites this paper
• Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.

  2007cites this paper
• Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes.

  2006cites this paper
• Chemokines in Children With Heterozygous Familiar Hypercholesterolemia: Selective Upregulation of RANTES

  2006cites this paper
• Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible Role in Plaque Destabilization

  2006cites this paper
• Expression of Fractalkine (CX3CL1) and its Receptor, CX3CR1, Is Elevated in Coronary Artery Disease and Is Reduced During Statin Therapy

  2005cites this paper
• Systemic effects of interferons after oral administration in animals and humans.

  2005cites this paper
• Antiinflammatory Effects of Tetradecylthioacetic Acid Involve Both Peroxisome Proliferator–Activated Receptor α–Dependent and –Independent Pathways

  2005cites this paper
• Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure

  2005cites this paper
• Endogenous IFN-α Production by Plasmacytoid Dendritic Cells Exerts an Antiviral Effect on Thymic HIV-1 Infection1

  2004cites this paper
• Endogenous IFN-alpha production by plasmacytoid dendritic cells exerts an antiviral effect on thymic HIV-1 infection.

  2004cites this paper
• Antiviral Effect on Thymic HIV-1 Infection Plasmacytoid Dendritic Cells Exerts an Production by a Endogenous IFN-Hergen

  2004cites this paper
• Elevated Levels of Activin A in Heart Failure: Potential Role in Myocardial Remodeling

  2004cites this paper
• Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure.

  2003cites this paper
• Remote abscess formation during interferon-alpha therapy for viral hepatitis.

  2003cites this paper
• Remote abscess formation during interferon-α therapy for viral hepatitis

  2003cites this paper
• Interleukin-7–Mediated Inflammation in Unstable Angina: Possible Role of Chemokines and Platelets

  2003cites this paper
• Effects of interferon‐α on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV‐infected patients

  2002cites this paper
• Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients.

  2002cites this paper
• Enhancement of Natural Killer Cell Activation and Antibody-Dependent Cellular Cytotoxicity by Interferon-α and Interleukin-12 in Vaginal Mucosae SIVmac251-Infected Macaca fascicularis

  2002cites this paper
• Endogenous and exogenous interferons in HIV-infection.

  2001cites this paper